A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
about
Tumor immunotargeting using innovative radionuclidesContribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate.Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imagingProspects in folate receptor-targeted radionuclide therapyFolate receptor targeted alpha-therapy using terbium-149.GPI transamidase and GPI anchored proteins: oncogenes and biomarkers for cancer.Synthesis and biological evaluation of (68) Ga-labeled Pteroyl-Lys conjugates for folate receptor-targeted tumor imaging.Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate.Neodymium-140 DOTA-LM3: Evaluation of an In Vivo Generator for PET with a Non-Internalizing VectorTheranostics in nuclear medicine practiceDevelopment of novel radionuclides for medical applications.PET Radiometals for Antibody Labeling.Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.Advances in targeting the folate receptor in the treatment/imaging of cancers.
P2860
Q28083230-F04AFFD0-EC90-454D-BEF8-A142F0A22542Q36564103-DD509222-A38F-45B4-9D01-47CA28AB1A93Q36828665-50C32189-E0AC-4E69-B76A-661E50B5410CQ37193061-C588CF1B-3781-489B-B47A-5136FFA7E126Q37689807-0BA31AEF-7D14-4984-8804-A3CF43A0FA37Q38131553-7B71C9F4-E086-40B5-88A5-6119316BC0ADQ38763433-5875F380-5528-4B47-A1D6-C3FDA93E5E95Q39338039-2FA1848D-0387-469A-A960-19258F74A91DQ40986557-D655D55A-748E-46CE-9760-C983291C918BQ42373162-16ECEED9-9C4A-404C-9347-3C9DEF88F6DCQ47645039-508A12D9-555B-4E09-9179-9B887BC21C93Q48228929-E48F05DA-A9FD-4C74-8800-4509AE667B29Q50499472-365314CA-E393-47AA-86B7-B72CE522D577Q55315165-3CFF483E-CB56-4843-9FCE-5AEDDCB21C46
P2860
A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A unique matched quadruplet of ...... or-targeted folate derivative.
@en
A unique matched quadruplet of ...... or-targeted folate derivative.
@nl
type
label
A unique matched quadruplet of ...... or-targeted folate derivative.
@en
A unique matched quadruplet of ...... or-targeted folate derivative.
@nl
prefLabel
A unique matched quadruplet of ...... or-targeted folate derivative.
@en
A unique matched quadruplet of ...... or-targeted folate derivative.
@nl
P2093
P1476
A unique matched quadruplet of ...... or-targeted folate derivative.
@en
P2093
Alexander Hohn
Andreas Türler
Cristina Müller
Holger Dorrer
Karl Johnston
Konstantin Zhernosekov
Nico T van der Walt
Ulli Köster
P304
P356
10.2967/JNUMED.112.107540
P407
P577
2012-11-08T00:00:00Z